Voorbeelden van het gebruik van Low body weight in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Patients with low body weight(< 60 kg)
which may make correct dosing easier for children and patients with low body weight or difficulties to swallow film- coated tablets.
General risk factors for bleeding include older age(however, no dose adjustment is necessary in the elderly(see section 5.2)), low body weight, and reduced renal or hepatic function.
sports where low body weight is considered to improve performances(e.g. dancing,
In general, the type and frequency of adverse events reported in patients with low body weight(≤ 60 kg) were similar to those of patients with higher weight(> 60 kg); however, the placebo- corrected
Female gender, lower body weight, and underlying renal impairment.
These differences are primarily explained by the lower body weight in females.
For children with a lower body weight a different dosage is recommended.
This is partly related to lower body weight.
patients with lower body weight and those with underlying renal impairment see section 5.2.
this can be explained by the generally lower body weight of women.
The lower body weight of the mice in the fasting group was not the only effect.
These components can be associated with lower body weight and less weight gain over time.
likely attributable to lower body weight.
The high strength steel also helps us to meet with new governmental regulations for special vehicles, lower body weight and higher demands on transportation efficiency.
In paediatric patients there is a general trend towards low bioavailability at lower body weights and high bioavailability at higher body weights approaching the extent.
however at toxic dose levels of telmisartan an effect on the postnatal development of the offspring such as lower body weight and delayed eye opening was observed.
of a teratogenic effect, but animal studies indicated some hazardous potential of telmisartan to the postnatal development of the offspring such as lower body weight, delayed eye opening,
In paediatric patients there is a general trend towards low bioavailability at lower body weights and high bioavailability at higher body weights approaching the extent demonstrated in adults.
In patients with lower body weights(< 59 kg,